Amgen CEO Kevin Sharer to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference Read more about Amgen CEO Kevin Sharer to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis May Be Under-Treated Read more about Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis May Be Under-Treated
Amgen Announces Put Option for Liquid Yield Option Notes Due 2032 and Zero Coupon Convertible Notes Due 2032 Read more about Amgen Announces Put Option for Liquid Yield Option Notes Due 2032 and Zero Coupon Convertible Notes Due 2032
Amgen's Fourth Quarter 2006 Revenue Increased 17% to $3.8 Billion; Full Year 2006 Revenue Increased 15% to $14.3 Billion Read more about Amgen's Fourth Quarter 2006 Revenue Increased 17% to $3.8 Billion; Full Year 2006 Revenue Increased 15% to $14.3 Billion
Amgen Launches 2007 Breakaway from Cancer Initiative Read more about Amgen Launches 2007 Breakaway from Cancer Initiative
Amgen Donates $1.1 Million to The Wellness Community as Part of of ``Breakaway from Cancer'' Initiative and Title Sponsorship of Amgen Tour of California Read more about Amgen Donates $1.1 Million to The Wellness Community as Part of of ``Breakaway from Cancer'' Initiative and Title Sponsorship of Amgen Tour of California
Amgen Announces Webcast of 2006 Fourth Quarter and Full Year Financial Results Read more about Amgen Announces Webcast of 2006 Fourth Quarter and Full Year Financial Results
Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure Read more about Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
Amgen Announces $5 Billion Stock Repurchase Plan Read more about Amgen Announces $5 Billion Stock Repurchase Plan
Updated Interim Long-Term Follow-up Data Reported AMG 531 Dosed Once Weekly Increased and Sustained Platelet Counts in Patients with Immune Platelet Disorder Read more about Updated Interim Long-Term Follow-up Data Reported AMG 531 Dosed Once Weekly Increased and Sustained Platelet Counts in Patients with Immune Platelet Disorder
